These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24492222)

  • 21. The economics of counterfeit Avastin: a geospatial and statistical analysis of demographic correlates to FDA warning letters.
    Cuomo RE; Mackey TK; Stigler P
    Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):748-56. PubMed ID: 26016718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Legislations combating counterfeit drugs in Hong Kong.
    Lai CW; Chan WK
    Hong Kong Med J; 2013 Aug; 19(4):286-93. PubMed ID: 23687210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. All the players in the game: driving home the global commitment for legitimate drugs.
    Babyar J
    Drug Dev Ind Pharm; 2018 Nov; 44(11):1868-1870. PubMed ID: 30114946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Operation Pangea - standing together in combat against international pharmaceutical crime].
    Smolka K; Gronwald K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1233-1239. PubMed ID: 28929174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drugs, drugs--who has the drugs?
    Blair J
    J Healthc Prot Manage; 2012; 28(1):28-32. PubMed ID: 22423518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drugs over the borders].
    Thirstrup S
    Ugeskr Laeger; 2011 Oct; 173(42):2633. PubMed ID: 22027160
    [No Abstract]   [Full Text] [Related]  

  • 27. [Impact of European e-commerce liberalisation on pharmaceutical crime : The ALPhA research project].
    Sinn A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1245-1254. PubMed ID: 28929171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The global pandemic of falsified medicines: laboratory and field innovations and policy perspectives.
    Nayyar GML; Breman JG; Herrington JE
    Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):2-7. PubMed ID: 25897072
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of the Pompidou Group of the Council of Europe in combating drug abuse and illicit drug trafficking.
    Brulé C
    Bull Narc; 1983; 35(4):73-7. PubMed ID: 6563929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Task force for falsified medicines].
    Weber G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1240-1244. PubMed ID: 28905078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the Association of South-East Asian Nations in fighting illicit drug traffic.
    Yodmani C
    Bull Narc; 1983; 35(4):97-104. PubMed ID: 6563932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Action by the Customs Co-operation Council to combat illicit drug trafficking.
    Gotschlich GD
    Bull Narc; 1983; 35(4):79-81. PubMed ID: 6563930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Missourians face risk in counterfeit medicines.
    Lawler T
    Mo Med; 2009; 106(3):177-82. PubMed ID: 22641912
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of the pharmacist in preventing distribution of counterfeit medications.
    Chambliss WG; Carroll WA; Kennedy D; Levine D; Moné MA; Ried LD; Shepherd M; Yelvigi M
    J Am Pharm Assoc (2003); 2012; 52(2):195-9. PubMed ID: 22370383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The crime of fake medicines.
    Deleuze J
    Rev Prat; 2016 May; 66(5):467. PubMed ID: 30748155
    [No Abstract]   [Full Text] [Related]  

  • 36. Tackling the booming trade in counterfeit drugs.
    Siva N
    Lancet; 2010 Nov; 376(9754):1725-6. PubMed ID: 21132864
    [No Abstract]   [Full Text] [Related]  

  • 37. An exploration of counterfeit medicine surveillance strategies guided by geospatial analysis: lessons learned from counterfeit Avastin detection in the US drug supply chain.
    Cuomo RE; Mackey TK
    BMJ Open; 2014 Dec; 4(12):e006657. PubMed ID: 25468507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Counterfeit medicines in Poland: opinions of primary healthcare physicians, nurses and lay persons.
    Binkowska-Bury M; Januszewicz P; Wolan M; Sobolewski M; Krauze M; Fijalek ZE
    J Clin Nurs; 2013 Feb; 22(3-4):559-68. PubMed ID: 22805373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of existing and emerging digital technologies to combat the global trade in fake medicines.
    Mackey TK; Nayyar G
    Expert Opin Drug Saf; 2017 May; 16(5):587-602. PubMed ID: 28349715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Penal measures for drug offences: perspectives from some Asian countries.
    Jayasuriya DC
    Bull Narc; 1984; 36(3):9-13. PubMed ID: 6570654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.